Rock Springs Capital Management LP Galapagos Nv Transaction History

Rock Springs Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$52.17 - $70.2 $8.61 Million - $11.6 Million	-165,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$96.85 - $148.25 $968,500 - $1.48 Million	-10,000 Reduced 5.71%	165,000 $16.3 Million
Q3 2019 Nov 14, 2019	BUY	$130.44 - $187.64 $1.3 Million - $1.88 Million	10,000 Added 6.06%	175,000 $26.7 Million
Q1 2019 May 15, 2019	SELL	$89.61 - $117.78 $1.12 Million - $1.47 Million	-12,500 Reduced 7.04%	165,000 $19.4 Million
Q3 2018 Nov 14, 2018	SELL	$90.63 - $120.22 $679,725 - $901,650	-7,500 Reduced 4.05%	177,500 $20 Million
Q4 2017 Feb 14, 2018	SELL	$84.48 - $104.02 $2.45 Million - $3.02 Million	-29,000 Reduced 13.55%	185,000 $17.3 Million
Q3 2017 Nov 14, 2017	BUY	$73.17 - $103.47 $15.7 Million - $22.1 Million	214,000	214,000 $21.8 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.69B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.